Shafique Virani

Insider Reports History

Location
Salt Lake City, UT
Signature
/s/ Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shafique Virani:

Company Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Business Officer Class A Common Stock 136,748 $1,446,192 $10.58 16 Jan 2024 Direct
RECURSION PHARMACEUTICALS, INC. Chief Business Officer Stock Option (Right to Buy) 361,469 16 Jan 2024 Direct

Insider Reports Filed by Shafique Virani

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RXRX RECURSION PHARMACEUTICALS, INC. 16 Jan 2024 3 -$156,780 4 Chief Business Officer 18 Jan 2024, 18:39
RXRX RECURSION PHARMACEUTICALS, INC. 15 Dec 2023 3 -$132,840 4 Chief Business Officer 19 Dec 2023, 19:22
RXRX RECURSION PHARMACEUTICALS, INC. 15 Nov 2023 4 -$103,090 4 Chief Business Officer 17 Nov 2023, 17:52
RXRX RECURSION PHARMACEUTICALS, INC. 16 Oct 2023 3 -$73,440 4 Chief Business Officer 18 Oct 2023, 17:34
RXRX RECURSION PHARMACEUTICALS, INC. 15 Sep 2023 3 -$115,920 4 Chief Business Officer 19 Sep 2023, 17:50
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2023 4 -$159,652 4 Chief Business Officer 17 Aug 2023, 18:39
RXRX RECURSION PHARMACEUTICALS, INC. 25 Jul 2023 6 -$485,400 4 Chief Business Officer 27 Jul 2023, 18:31
RXRX RECURSION PHARMACEUTICALS, INC. 17 Jul 2023 6 -$630,600 4 Chief Business Officer 19 Jul 2023, 19:01
RXRX RECURSION PHARMACEUTICALS, INC. 15 Jun 2023 6 -$439,200 4 Chief Business Officer 20 Jun 2023, 18:56
RXRX RECURSION PHARMACEUTICALS, INC. 01 Jun 2023 2 -$374,034 4 Chief Business Officer 05 Jun 2023, 18:29
RXRX RECURSION PHARMACEUTICALS, INC. 15 May 2023 1 -$12,488 4 Chief Business Officer 17 May 2023, 18:20
RXRX RECURSION PHARMACEUTICALS, INC. 15 Feb 2023 5 -$66,922 4 Chief Business Officer 17 Feb 2023, 16:13
RXRX RECURSION PHARMACEUTICALS, INC. 01 Feb 2023 4 -$25,599 4 Chief Business Officer 03 Feb 2023, 16:12
RXRX RECURSION PHARMACEUTICALS, INC. 17 Jan 2023 3 -$80,461 4 Chief Business Officer 19 Jan 2023, 16:01
RXRX RECURSION PHARMACEUTICALS, INC. 15 Dec 2022 3 -$77,425 4 Chief Business Officer 19 Dec 2022, 16:32
RXRX RECURSION PHARMACEUTICALS, INC. 15 Nov 2022 5 -$119,293 4 Chief Business Officer 17 Nov 2022, 17:47
RXRX RECURSION PHARMACEUTICALS, INC. 14 Oct 2022 4 -$98,080 4 Chief Business Officer 18 Oct 2022, 17:08
RXRX RECURSION PHARMACEUTICALS, INC. 15 Sep 2022 4 -$122,535 4 Chief Business Officer 16 Sep 2022, 18:58
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2022 4 -$330,888 4 Chief Business Officer 17 Aug 2022, 18:35
RXRX RECURSION PHARMACEUTICALS, INC. 16 May 2022 1 -$4,933 4 Chief Corp. Dev. Officer 18 May 2022, 19:20
RXRX RECURSION PHARMACEUTICALS, INC. 04 Feb 2022 5 -$12,700 4 Chief Corp. Dev. Officer 08 Feb 2022, 20:11
RXRX RECURSION PHARMACEUTICALS, INC. 02 Jun 2021 2 +$100,000 4 Chief Corp. Dev. Officer 04 Jun 2021, 16:00